Combination of Docetaxel, Epirubicin and Vinorelbine Administered Every 2 Weeks as First-line Therapy in Patients with Metastatic Breast Cancer: A Dose-finding Study

2003 ◽  
Vol 80 (3) ◽  
pp. 257-265 ◽  
Author(s):  
Emilio Esteban ◽  
Antonio Modollel ◽  
Luis González de Sande ◽  
Isabel Palacio ◽  
Isabel Muñiz ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Dose Finding ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Finding Study ◽  
Dose Finding Study

scholarly journals Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer

1999 ◽  
Vol 10 (5) ◽  
pp. 553-560 ◽  
Author(s):  
J.L. Misset ◽  
V. Dieras ◽  
G. Gruia ◽  
H. Bourgeois ◽  
E. Cvitkovic ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Dose Finding ◽  
Line Treatment ◽  
First Line ◽  
Finding Study ◽  
Dose Finding Study ◽  
First Line Treatment

Phase II Trial of Weekly Vinorelbine and Trastuzumab as First‐Line Therapy in Patients with HER2 + Metastatic Breast Cancer

2002 ◽  
Vol 7 (5) ◽  
pp. 410-417 ◽  
Author(s):  
Mohammad Jahanzeb ◽  
Joanne E. Mortimer ◽  
Furhan Yunus ◽  
David H. Irwin ◽  
James Speyer ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

High-Dose Epirubicin + Cyclophosphamide (HD-EC) in Metastatic Breast Cancer: A Dose-Finding Study

1988 ◽  
Vol 11 (6) ◽  
pp. 287-288 ◽  
Author(s):  
G.A. Nagel ◽  
J.-H. Beyer ◽  
W. Holtkamp ◽  
D. Emrich ◽  
M. Kneba ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Dose Finding ◽  
High Dose ◽  
Finding Study ◽  
Dose Finding Study
Sign in / Sign up

Export Citation Format

Share Document